[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354249-105":59,"doc-detail-354249-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","machine-learning-based-models-for-tumor-mutation-burden-prediction-in-gastrointestinal-cancers-a-systematic-review-and-meta-analysis","Machine learning-based models for tumor mutation burden prediction in gastrointestinal cancers: a systematic review and meta-analysis","","Tumor mutation burden (TMB) functions as a key biomarker for immunotherapy guidance in gastrointestinal (GI) cancers, but whole-exome sequencing (WES) measurement is costly and invasive. Machine learning (ML)-based models and radiogenomics are promising non-invasive alternatives, while diagnostic performance and methodological consistency are uncertain. This systematic review and meta-analysis evaluates diagnostic performance, methodological rigor, and reporting quality of ML models for TMB prediction using QUADAS-2 adapted tools and pooled AUC and accuracy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/machine-learning-based-models-for-tumor-mutation-burden-prediction-in-gastrointestinal-cancers-a-systematic-review-and-meta-analysis/354249/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/machine-learning-based-models-for-tumor-mutation-burden-prediction-in-gastrointestinal-cancers-a-systematic-review-and-meta-analysis/354249.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is tumor mutation burden (TMB) important in gastrointestinal cancers?","Question",{"text":112,"@type":113},"TMB is a pivotal biomarker linked to neoantigen formation and immune activation. Higher TMB levels are associated with improved responses to immune checkpoint inhibitors and can support patient stratification for immunotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What methods were used to evaluate ML models for TMB prediction?",{"text":117,"@type":113},"PubMed, Scopus, and Web of Science were searched through January 2025 for studies using ML or deep learning to predict TMB in human GI cancers. Risk of bias was assessed with a QUADAS-2 framework adapted for AI prediction studies, and pooled AUC and accuracy were computed with random-effects meta-analysis, alongside heterogeneity and sensitivity analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the meta-analysis find about diagnostic performance and model types?",{"text":121,"@type":113},"Ten studies met inclusion criteria, with pooled AUC around 0.89 and pooled accuracy around 0.86. Graph neural networks showed the most stable performance (AUC approximately 0.97), while classical ML models performed consistently on smaller datasets. Publication bias was significant for AUC but not for accuracy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354249,1790210643,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Rahimi etal. Discover Oncology (2026) 17:815 [https://doi.org/10.1007/s12672-026-04807-6](https://doi.org/10.1007/s12672-026-04807-6)  \nDiscover Oncology  \nREVIEW Open Access  \nMachine learning-based models for tumor  mutation burden prediction in gastrointestinal cancers: a systematic review and meta-analysis  \nParsa Rahimi 1†, Farnaz Atighi2†, Behandokht Rezaei3†, Helia Rezaee3†, Muhammed Abdelbaset4, Fatemeh Nazari5, Shahrzad Zarrehparvar Ghouchani Nezhad5, Mobina Moradi Kashkoli6, Anis Ghaffarzadeh7,  \nFatemehsadat Taghavi8, Parsa Goudarzi3, Amirsaeed Samavarchitehrani5, Amir Marashi3, Yasaman Esmaeili6, Farahnaz Zhian Zargaran9*, Ahmadreza Shirdel9*, Mahsa Asadi Anar3* and Sajedeh Mousavi 10  \n†Parsa Rahimi, Farnaz Atighi, Behandokht Rezaei and Helia Rezaee contributed equally to this work.  \n*Correspondence:  \nFarahnaz Zhian Zargaran  \ndr.farahnazzhianzaragaran@gmail. com  \nAhmadreza Shirdel [Ahmadrezashirdel@gmail.com](Ahmadrezashirdel@gmail.com)[ ](Ahmadrezashirdel@gmail.com)Mahsa Asadi Anar[asadianar@arizona.edu](asadianar@arizona.edu); Mahsa. [boz@gmail.com](boz@gmail.com)  \nFull list of author information is available at the end of the article  \nAbstract  \nBackground Tumor mutation burden (TMB) serves as a key biomarker guiding immunotherapy in gastrointestinal (GI) cancers, yet its measurement via whole-exome sequencing (WES) is costly and invasive. Machine learning (ML)-based models and radiogenomics provide promising non-invasive alternatives, but their diagnostic performance and methodological consistency remain unclear.  \nObjective To systematically evaluate and meta-analyze the diagnostic performance, methodological rigor, and reporting quality of ML-based models developed forTMB prediction in GI cancers.  \nMethods PubMed, Scopus, and Web of Science were searched through January 2025 for studies applying ML or deep learning to predict TMB in human GI cancers. Risk of bias was assessed using the Cochrane QUADAS-2 framework adapted for AI prediction studies. Pooled estimates for area under the curve (AUC) and accuracy were obtained under a restricted maximum-likelihood random-effects model, with heterogeneity quantified by I² and sensitivity analyses exploring threshold effects. Deeks’ funnel asymmetry test was used to assess publication bias. Subgroup analyses examined cancer type and model architecture.  \nResults Ten studies met inclusion criteria. The pooled AUC was 0.89 (95% CI 0.80–0. 97; I² = 92 . 1%), and pooled accuracy was 0.86 (95% CI 0 .79–0. 94; I² = 83 . 9%) . Graph neural networks achieved the most stable performance (AUC ≈ 0. 97), while classical ML models showed consistent results on smaller datasets. Publication bias was significant for AUC (p = 0 . 007) but not for accuracy (p = 0 . 15), indicating outcome-specific reporting tendencies. Only 3/10 studies performed external validation, and calibration metrics were rarely reported. Subgroup findings suggested that heterogeneity stemmed more from model architecture and dataset design than from cancer subtype. Conclusion ML-based and radiogenomic models demonstrate high diagnostic potential for predicting TMB in GI cancers, particularly with graph-based architectures. However, scarce external validation, inconsistent TMB definitions, and selective  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the ","cbCaifmhcRDz946n","https://ap.wps.com/l/cbCaifmhcRDz946n","pdf",2470108,22,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusion\n# Keywords\n# 1 Introduction","[{\"question\":\"Why is tumor mutation burden (TMB) important in gastrointestinal cancers?\",\"answer\":\"TMB is a pivotal biomarker linked to neoantigen formation and immune activation. Higher TMB levels are associated with improved responses to immune checkpoint inhibitors and can support patient stratification for immunotherapy.\"},{\"question\":\"What methods were used to evaluate ML models for TMB prediction?\",\"answer\":\"PubMed, Scopus, and Web of Science were searched through January 2025 for studies using ML or deep learning to predict TMB in human GI cancers. Risk of bias was assessed with a QUADAS-2 framework adapted for AI prediction studies, and pooled AUC and accuracy were computed with random-effects meta-analysis, alongside heterogeneity and sensitivity analyses.\"},{\"question\":\"What did the meta-analysis find about diagnostic performance and model types?\",\"answer\":\"Ten studies met inclusion criteria, with pooled AUC around 0.89 and pooled accuracy around 0.86. Graph neural networks showed the most stable performance (AUC approximately 0.97), while classical ML models performed consistently on smaller datasets. Publication bias was significant for AUC but not for accuracy.\"}]","Machine learning-based models for tumor mutation burden prediction in gastrointestinal cancers: a systematic review and meta-analysis | PDF",1790109722,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bcf4917a0099eecf4b1fbbec6bba3544.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5054696f262c716312aa722affd4dc7a.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/346fe6a7c0729a67202a8301511e344b.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c12db9350f52342ad12ff8a7884cbe75.webp",980,1306]